Richard Jove, Ph.D.
Institute Director



Dr. Richard Jove is committed to developing more effective and safer therapies for the treatment of cancer and infectious diseases as well as other diseases impacted by aging and inflammation. His own research program has focused on signaling pathways involved in cancers, particularly tyrosine kinases, and development of new molecular targeted therapies against these pathways. He is widely recognized for his pioneering research on the roles of IL6/JAK/STAT3 signaling in tumor progression and immune responses.

Dr. Jove’s predoctoral training at Columbia University and postdoctoral training at Rockefeller University, New York, prepared him well for his scientific and leadership roles. He began his independent research career as an Assistant Professor at the University of Michigan, Ann Arbor, where he served as Leader of the NCI Molecular Oncology Program and was subsequently promoted to Associate Professor with Tenure.

After nearly a decade in Ann Arbor, Dr. Jove was recruited to help establish the Moffitt Cancer Center, Tampa FL, serving as Professor and Director of the NCI Molecular Oncology Program for nearly a decade and then as Associate Director for Basic Research. Since 2005, Dr. Jove first served as Chair of Molecular Medicine for two years and for the next five years as Director of the Beckman Research Institute at City of Hope in Los Angeles, CA. As Deputy Director of the City of Hope Comprehensive Cancer Center at the same time until 2012, one of his primary roles was to integrate the cancer research activities of the Beckman Research Institute and the NCI Comprehensive Cancer Center.

In his leadership capacity as Director and President of VGTI Florida, his priority is fostering collaboration for development of original scientific discoveries into innovative therapies for early phase clinical trials in infectious diseases, cancer and related diseases. He has had continuous uninterrupted NIH grant funding since establishing his first lab in 1988 and published well over 200 research articles to date. As of July 1, 2013, Dr. Jove has been serving as the new Director of VGTI Florida®.